474330-54-6

Basic information

• Product Name: 5-aMino-2-broMo-4-Methylbenzoic acid Methyl ester
• Synonyms: 5-aMino-2-broMo-4-Methylbenzoic acid Methyl ester;Methyl 5-aMino-2-broMo-4-Methylbenzoate;Benzoic acid, 5-aMino-2-broMo-4-Methyl-, Methyl ester;methyl 5-amino-2-bromo-4-methylbenzoate hydrochloride
• CAS NO: 474330-54-6
• Molecular Formula: C₉H₁₀BrNO₂
• Molecular Weight: 244.0852
• EINECS: 1533716-785-6
• Mol File: 474330-54-6.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 328.4±37.0 °C(Predicted)
• Appearance: /
• Density: 1.506±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 2.60±0.10(Predicted)
• CAS DataBase Reference: 5-aMino-2-broMo-4-Methylbenzoic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-aMino-2-broMo-4-Methylbenzoic acid Methyl ester(474330-54-6)
• EPA Substance Registry System: 5-aMino-2-broMo-4-Methylbenzoic acid Methyl ester(474330-54-6)

Safety Data

• Hazardous Substances Data: 474330-54-6(Hazardous Substances Data)

Usage

General Description

5-Amino-2-bromo-4-methylbenzoic acid methyl ester is a chemical compound that belongs to the class of benzoic acid derivatives. It is a methyl ester derivative of 5-amino-2-bromo-4-methylbenzoic acid and is used in the synthesis of pharmaceuticals and other organic compounds. 5-aMino-2-broMo-4-Methylbenzoic acid Methyl ester may have potential uses in the development of new drugs or as a building block for the production of various organic compounds. Its specific properties and uses may vary depending on the specific application and synthesis process.

Upstream product

• 67-56-1 methanol 
• 745048-63-9 5-amino-2-bromo-4-methylbenzoic acid 
• 18595-18-1 3-amino-4-methyl benzoic acid methyl ester 
• 2458-12-0 3-amino-p-toluic acid 

Downstream Products

• 1061314-02-0 2-bromo-5-chloro-4-methyl-benzoic acid methyl ester 
• 1204304-98-2 C₉H₈BrFO₂ 
• 1313513-42-6 methyl 4-(acetoxymethyl)-2-bromo-5-chlorobenzoate 
• 1313513-41-5 methyl 2-bromo-4-(bromomethyl)-5-chlorobenzoate 
• 1313513-39-1 2-bromo-5-chloro-4-(hydroxymethyl)benzoic acid 
• 1352713-57-5 triisopropylsilyl 2-bromo-5-chloro-4-((triisopropylsilyloxy)methyl)benzoate 
• 1313513-46-0 (2-bromo-5-chloro-4-((triisopropylsilyloxy)methyl)phenyl)methanol 
• 1313513-44-8 (4-(allyloxymethyl)-5-bromo-2-chlorobenzyloxy)triisopropylsilane 
• 1061314-06-4 [2-bromo-5-chloro-4-(4-ethylbenzyl)phenyl]methanol 
• 1061314-08-6 1-(allyloxymethyl)-2-bromo-5-chloro-4-(4-ethylbenzyl)-benzene 
• 1061314-20-2 (2S,3S,4R,5R,6R)-2-(2-(allyloxymethyl)-4-chloro-5-(4-ethylbenzyl)phenyl)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran 
• 1061314-50-8 (5-chloro-4-(4-ethylbenzyl)-2-((2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-2-yl)-phenyl)methanol 
• 1204220-87-0 5-chloro-4-(4-ethylbenzyl)-2-[(2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-2-yl]benzoic acid 
• 1427370-50-0 (2R,3S,4S,4aR,10bS)-8-chloro-9-(4-ethylbenzyl)-3,4-dihydroxy-2-(hydroxymethyl)-3,4,4a,10b-tetrahydropyrano[3,2-c][2]benzopyran-6(2H)-one 

Relevant articles and documents

Substituted triazole compound, pharmaceutical composition containing substituted triazole compound, preparation method and application of substituted triazole compound

The present invention relates to a substituted triazole compound represented by formula (I), a pharmaceutical compositions comprising the substituted triazole compound, a preparation method of the substituted triazole compound, and applications of the sub

A new and improved process for C-aryl glucoside SGLT2 inhibitors

A practical and scalable synthesis of C-glycosides identified as highly potent sodium-dependent glucose transporter 2 (SGLT2) inhibitors is described. Highlights of the synthetic process are a concise, ten-step synthesis of a structurally complex active pharmaceutical ingredient from a known intermediate via a selective and quantitative addition of an aryl species to the Weinreb amide, and the isomers of undesired ortho-products were avoided during the preparation. The chemistry developed has been applied to prepare SGLT2 inhibitors without recourse to chromatography.

Pyrano[3,2-c]benzopyran-6(2h)-one derivatives and uses thereof

The present invention relates to new pyrano[3,2-c]benzopyran-6(2H)-one derivatives that act as SGLT2 inhibitors, which makes them promising candidates for the treatment of diabetes and other diseases and conditions mediated by SGLT2. These new drugs also exhibit platelet aggregation inhibitory activity which makes them promising candidates in the treatment and/or prevention of prothrombotic conditions. The invention also relates to the use of such pyrano[3,2-c]benzopyran-6(2H)-one derivatives in the treatment or prevention of the diabetes and other disorders and conditions mediated by SGLT2, as a single active ingredient or in combination with another antidiabetic agent or a drug for the treatment of hypertension, chronic heart failure or atherosclerosis, and pharmaceutical compositions comprising said new pyrano[3,2-c]benzopyran-6(2H)-one derivatives.